Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen.
Movahedin, M., Brooks, T.M., Supekar, N.T., Gokanapudi, N., Boons, G.J., Brooks, C.L.(2017) Glycobiology 27: 677-687
- PubMed: 28025250 
- DOI: 10.1093/glycob/cww131
- Primary Citation of Related Structures:  
5T6P, 5T78 - PubMed Abstract: 
In cancer cells, the glycoprotein Mucin 1 (MUC1) undergoes abnormal, truncated glycosylation. The truncated glycosylation exposes cryptic peptide epitopes that can be recognized by antibodies. Since these immunogenic regions are cancer specific, they ...